BlossomHill Therapeutics, Inc.
BLSM
11 insider filings · Latest: Aug 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Aug 12 8:46 PM | Carl L GordonDirector | Purchase | 625,000 | $16.00 | $10.0M | 2,714,279(I) | View → |
| Aug 10, 2026 | Aug 12 8:43 PM | ORBIMED ADVISORS LLCDirector | Purchase | 625,000 | $16.00 | $10.0M | 2,714,279(I) | View → |
| Aug 10, 2026 | Aug 10 10:35 PM | John P. SchmidDirector | Purchase | 6,000 | $16.00 | $96.0K | 6,000(D) | View → |
| Aug 10, 2026 | Aug 10 10:32 PM | Bihua ChenDirector, 10% Owner | Purchase | 312,500 | $16.00 | $5.0M | 3,614,034(I) | View → |
| Aug 10, 2026 | Aug 10 10:27 PM | Jason A KeyesChief Financial Officer | Purchase | 700 | $16.00 | $11.2K | 700(D) | View → |
| Aug 10, 2026 | Aug 10 10:26 PM | Vincent Paul LiptakGeneral Counsel | Purchase | 2,200 | $16.00 | $35.2K | 111,412(D) | View → |
| Aug 7, 2026 | Aug 10 10:26 PM | Vincent Paul LiptakGeneral Counsel | Purchase | 2,500 | $15.80 | $39.5K | 109,212(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Aug 12 8:46 PM | Carl L GordonDirector | Conversion | 2,089,279 | — | 0(I) | View → |
| Aug 10, 2026 | Aug 12 8:43 PM | ORBIMED ADVISORS LLCDirector | Conversion | 2,089,279 | — | 0(I) | View → |
| Aug 6, 2026 | Aug 10 10:33 PM | Carl L GordonDirector | Grant/Award | 23,904 | $16.00 | 23,904(D) | View → |
| Aug 10, 2026 | Aug 10 10:32 PM | Bihua ChenDirector, 10% Owner | Conversion | 3,301,534 | — | 0(I) | View → |
| Aug 6, 2026 | Aug 10 10:32 PM | Bihua ChenDirector, 10% Owner | Grant/Award | 23,904 | $16.00 | 23,904(D) | View → |
| Aug 10, 2026 | Aug 10 10:29 PM | Sundeep AgrawalDirector | Conversion | 578,524 | — | 0(I) | View → |
| Aug 6, 2026 | Aug 10 10:29 PM | Sundeep AgrawalDirector | Grant/Award | 23,904 | $16.00 | 23,904(D) | View → |
| Aug 6, 2026 | Aug 10 10:27 PM | Jason A KeyesChief Financial Officer | Grant/Award | 56,746 | $16.00 | 56,746(D) | View → |
| Aug 10, 2026 | Aug 10 10:26 PM | Vincent Paul LiptakGeneral Counsel | Conversion | 22,687 | — | 0(I) | View → |
| Aug 6, 2026 | Aug 10 10:26 PM | Vincent Paul LiptakGeneral Counsel | Grant/Award | 46,561 | $16.00 | 46,561(D) | View → |
| Aug 6, 2026 | Aug 10 10:24 PM | Geoffrey Raymond OxnardChief Medical Officer | Grant/Award | 61,783 | $16.00 | 61,783(D) | View → |
| Aug 10, 2026 | Aug 10 10:23 PM | Yishan LiDirector, Executive Chairman, 10% Owner | Conversion | 1,838,896 | — | 0(I) | View → |
| Aug 6, 2026 | Aug 10 10:23 PM | Yishan LiDirector, Executive Chairman, 10% Owner | Grant/Award | 112,701 | $16.00 | 112,701(D) | View → |
| Aug 10, 2026 | Aug 10 10:22 PM | Cui Jingrong JeanDirector, President and CEO, 10% Owner | Conversion | 1,838,896 | — | 0(I) | View → |
| Aug 6, 2026 | Aug 10 10:22 PM | Cui Jingrong JeanDirector, President and CEO, 10% Owner | Grant/Award | 676,205 | $16.00 | 676,205(D) | View → |